Which has the lower trailing P/E, MEDP or UTHR?

UTHR has the lower trailing P/E: MEDP trades at 35.63 and UTHR at 18.96. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, MEDP or UTHR?

Over the past five years, MEDP grew revenue faster — MEDP at a 22.03% CAGR versus UTHR at 14.68%.

Is MEDP or UTHR more profitable?

UTHR runs the higher net margin — MEDP at 17.67% versus UTHR at 41.56%.

How have MEDP and UTHR total returns compared?

Over the past 10 years, MEDP delivered 35.80% and UTHR delivered 15.35% annualized total return. Past performance doesn't predict future results.

Medpace Holdings, Inc. (MEDP) vs United Therapeutics Corporation (UTHR)

A side-by-side comparison of Medpace Holdings, Inc. and United Therapeutics Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 20, 2026. Differences are shown without an overall score or investment verdict.

MEDP

Medpace Holdings, Inc.

$16.98B

$608.27HealthcareAt close: Aug 19, 2026, 4:00 PM ET

UTHR

United Therapeutics Corporation

$22.46B

$529.14HealthcareAt close: Aug 19, 2026, 4:00 PM ET

Total return — MEDP vs UTHR

growth of $100 · dividends reinvested · last 10y

MEDP +2032.0% (+35.8%/yr)UTHR +322.6% (+15.5%/yr)MEDP compounded faster over this window

Log scale — wide-divergence pair

MEDP UTHR

MEDP vs UTHR: by the numbers

•UTHR is the larger company ($22.46B vs $16.98B market cap).
•UTHR trades at the lower trailing earnings multiple (18.96 vs 35.63 P/E), one valuation lens rather than an overall verdict.
•UTHR converts more revenue to profit (41.56% vs 17.67% net margin).
•MEDP grew revenue faster over the past five years (22.03% vs 14.68% CAGR).

Metrics side by side

Valuation

Metric	MEDP	UTHR
P/E ratio	35.63	18.96
Forward P/E	34.56	20.07
P/S ratio	6.29	7.68
P/B ratio	40.32	3.79
EV / EBITDA	28.00	15.01
FCF yield	4.19%	4.51%

Profitability

Metric	MEDP	UTHR
Gross margin	28.76%	86.14%
Operating margin	20.97%	44.49%
Net margin	17.67%	41.56%
ROE	113.29%	20.48%
ROIC	77.00%	17.69%

Growth (annualized)

Metric	MEDP	UTHR
Revenue CAGR (5Y)	22.03%	14.68%
EPS CAGR (5Y)	30.90%	20.93%
FCF CAGR (5Y)	23.40%	14.31%
Total return CAGR (5Y)	28.09%	21.36%

Frequently asked

Which has the lower trailing P/E, MEDP or UTHR?: UTHR has the lower trailing P/E: MEDP trades at 35.63 and UTHR at 18.96. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, MEDP or UTHR?: Over the past five years, MEDP grew revenue faster — MEDP at a 22.03% CAGR versus UTHR at 14.68%.
Is MEDP or UTHR more profitable?: UTHR runs the higher net margin — MEDP at 17.67% versus UTHR at 41.56%.
How have MEDP and UTHR total returns compared?: Over the past 10 years, MEDP delivered 35.80% and UTHR delivered 15.35% annualized total return. Past performance doesn't predict future results.

Go deeper

Full MEDP analysis Full UTHR analysis Interactive comparison tool

Dig into the metrics

Medpace P/E ratio United Therapeutics P/E ratio Medpace ROE United Therapeutics ROE Medpace operating margin United Therapeutics operating margin Medpace revenue growth United Therapeutics revenue growth Medpace free cash flow United Therapeutics free cash flow

Medpace & United Therapeutics appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 20, 2026.